** Shares of diagnostic firm OpGen rise 61% to 76 cents in extended trading
** Co says private investor David Lazar will replace Oliver Schacht as CEO
** Adds Lazar invests $3 mln in OpGen's preferred stock
** Proceeds of the transaction will be used to repay debt and for other general corporate and operating purposes -OPGN
** Up to last close, stock up 13% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments